Vol 4, No 8 (2024)

decorative image of the issue cover

Reimbursement Recommendations

Cabotegravir (Apretude)

CADTH

Published August 30, 2024

PDF HTML

Etrasimod (Velsipity)

CADTH

Published August 30, 2024

PDF HTML

Evolocumab (Repatha)

CADTH

Published August 26, 2024

PDF HTML

Relugolix (Orgovyx)

CADTH

Published August 8, 2024

PDF HTML

Health Technology Reviews

An Inventory of Rare Disease Registries in the Canadian Landscape

CADTH

Published August 29, 2024

PDF HTML

Review of Guidelines on Clonidine for Various Indications

CADTH

Published August 15, 2024

PDF HTML

Canadian Medical Imaging Inventory 2022–2023: CT

CADTH

Published August 14, 2024

PDF HTML

Canadian Medical Imaging Inventory 2022–2023: MRI

CADTH

Published August 14, 2024

PDF HTML

Canadian Medical Imaging Inventory 2022–2023: PET-CT and PET-MRI

CADTH

Published August 13, 2024

PDF HTML

Canadian Medical Imaging Inventory 2022–2023: SPECT and SPECT-CT

CADTH

Published August 14, 2024

PDF HTML

Canadian Medical Imaging Inventory 2022–2023: Provincial and Territorial Overview

CADTH

Published August 14, 2024

PDF HTML

Canadian Medical Imaging Inventory 2022–2023: The Medical Imaging Team

CADTH

Published August 14, 2024

PDF HTML

Canadian Medical Imaging Inventory 2022–2023: Methods

CADTH

Published August 14, 2024

PDF HTML

Health Technology Review Recommendation

Aging in Place

CADTH

Published August 19, 2024

PDF HTML

Reimbursement Reviews

Infliximab (Remsima SC)

CADTH

Published August 28, 2024

PDF HTML

Cannabidiol (Epidiolex)

CADTH

Published August 15, 2024

PDF HTML

View All Issues